Fol. Biol. 2014, 60, 28-34

https://doi.org/10.14712/fb2014060010028

Genetic Testing in the Management of Relatives of Patients with Hypertrophic Cardiomyopathy

Pavol Tomašov1, M. Minárik2, D. Zemánek1, P. Čadová1, S. Homolová1, K. Čurila3, M. Pěnička3, L. Benešová2, B. Belšánová2, P. Gregor3, J. Veselka1

1Department of Cardiology, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
2Laboratory for Molecular Genetics and Oncology, Genomac Research Institute, Prague, Czech Republic
3Third Department of Internal Medicine – Department of Cardiology, University Hospital Královské Vinohrady, Prague, Czech Republic

Received March 2013
Accepted June 2013

References

1. Burkett, E. L., Hershberger, R. E. (2005) Clinical and genetic issues in familial dilated cardiomyopathy. J. Am. Coll. Cardiol. 45, 969-981. <https://doi.org/10.1016/j.jacc.2004.11.066>
2. Charron, P., Carrier, L., Dubourg, O., Tesson, F., Desnos, M., Richard, P., Bonne, G., Guicheney, P., Hainque, B., Bouhour, J. B., Mallet, A., Feingold, J., Schwartz, K., Komajda, M. (1997) Penetrance of familial hypertrophic cardiomyopathy. Genet. Couns. 8, 107-114.
3. Charron, P., Dubourg, O., Desnos, M., Bennaceur, M., Carrier, L., Camproux, A. C., Isnard, R., Hagege, A., Langlard, J. M., Bonne, G., Richard, P., Hainque, B., Bouhour, J. B., Schwartz, K., Komajda, M. (1998) Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 97, 2230-2236. <https://doi.org/10.1161/01.CIR.97.22.2230>
4. Charron, P., Arad, M., Arbustini, E., Basso, C., Bilinska, Z., Elliott, P., Helio, T., Keren, A., McKenna, W. J., Monserrat, L., Pankuweit, S., Perrot, A., Rapezzi, C., Ristic, A., Seggewiss, H., van Langen, I., Tavazzi, L. (2010) Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 31, 2715-2728. <https://doi.org/10.1093/eurheartj/ehq271>
5. Dimitrow, P. P., Bober, M., Michałowska, J., Sorysz, D. (2009) Left ventricular outflow tract gradient provoked by upright position or exercise in treated patients with hypertrophic cardiomyopathy without obstruction at rest. Echocardiography 26, 513-520. <https://doi.org/10.1111/j.1540-8175.2008.00851.x>
6. Faita, F., Vecoli, C., Foffa, I., Andreassi, M. G. (2012) Next generation sequencing in cardiovascular diseases. World J. Cardiol. 4, 288-295. <https://doi.org/10.4330/wjc.v4.i10.288>
7. Gandjbakhch, E., Gackowski, A., du Montcel, S. T., Isnard, R., Hamroun, A., Richard, P., Komajda, M., Charron, P. (2010) Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler paging. Eur. Heart J. 31, 1599-1607. <https://doi.org/10.1093/eurheartj/ehq101>
8. Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., Seidman, C. E., Towbin, J. A., Udelson, J. E., Yancy, C. W.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation 124, 783-831.
9. Ho, C. Y., Sweitzer, N. K., McDonough, B., Maron, B. J., Casey, S. A., Seidman, J. G., Seidman, C. E., Solomon, S. D. (2002) Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 105, 2992-2997. <https://doi.org/10.1161/01.CIR.0000019070.70491.6D>
10. Kim, S. J., Iizuka, K., Kelly, R. A., Geng, Y. J., Bishop, S. P., Yang, G., Kudej, A., McConnell, B. K., Seidman, C. E., Seidman, J. G., Vatner, S. F. (1999) An α-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. Am. J. Physiol. 276, 1780-1787.
11. Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., Solomon, S. D., Spencer, K. T., Sutton, M. S., Stewart, W. J.; Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 18, 1440-1463. <https://doi.org/10.1016/j.echo.2005.10.005>
12. Marian, A. J., Roberts, R. (1994) Molecular basis of hypertrophic and dilated cardiomyopathy. Tex. Heart Inst. J. 21, 6-15.
13. Marian, A. J., Zhao, G., Seta, Y., Roberts, R., Yu, Q. T. (1997) Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. Circ. Res. 81, 76-85. <https://doi.org/10.1161/01.RES.81.1.76>
14. Marian, A. J. (2000) Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 355, 58-60. <https://doi.org/10.1016/S0140-6736(99)06187-5>
15. Maron, B. J., Niimura, H., Casey, S. A., Soper, M. K., Wright, G. B., Seidman, J. G., Seidman, C. E. (2001) Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J. Am. Coll. Cardiol. 38, 315-321. <https://doi.org/10.1016/S0735-1097(01)01386-9>
16. Maron, B. J., Maron, M. S. (2013) Hypertrophic cardiomyopathy. Lancet 381, 242-255. <https://doi.org/10.1016/S0140-6736(12)60397-3>
17. Michels, M., Soliman, O. I., Kofflard, M. J., Hoedemaekers, Y. M., Dooijes, D., Majoor-Krakauer, D., ten Cate, F. J. (2009) Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc. Imaging 2, 58-64. <https://doi.org/10.1016/j.jcmg.2008.08.003>
18. Niimura, H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H., Chudley, A. E., McKenna, W., Kristinsson, A., Roberts, R., Sole, M., Maron, B. J., Seidman, J. G., Seidman, C. E. (1998) Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N. Engl. J. Med. 338, 1248-1257. <https://doi.org/10.1056/NEJM199804303381802>
19. Palecek, T., Tesarova, M., Kuchynka, P., Dytrych, V., Elleder, M., Hulkova, H., Hansikova, H., Honzik, T., Zeman, J., Linhart, A. (2012) Hypertrophic cardiomyopathy due to the mitochondrial DNA mutation m.3303C>T diagnosed in an adult male. Int. Heart J. 53, 383-387. <https://doi.org/10.1536/ihj.53.383>
20. Varnava, A. M., Elliott, P. M., Baboonian, C., Davison, F., Davies, M. J., McKenna, W. J. (2001) Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 104, 1380-1384. <https://doi.org/10.1161/hc3701.095952>
21. Watkins, H., Thierfelder, L., Hwang, D. S., McKenna, W., Seidman, J. G., Seidman, C. E. (1992) Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J. Clin. Invest. 90, 1666-1671. <https://doi.org/10.1172/JCI116038>
22. Watkins, H., McKenna, W. J., Thierfelder, L., Suk, H. J., Anan, R., O’Donoghue, A., Spirito, P., Matsumori, A., Moravec, C. S., Seidman, J. G (1995) Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332, 1058-1064. <https://doi.org/10.1056/NEJM199504203321603>
23. Zemanek, D., Tomasov, P., Homolova, S., Linhartova, K., Veselka, J. (2011) Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy. Eur. J. Echocardiogr. 12, 684-687. <https://doi.org/10.1093/ejechocard/jer115>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Archive